Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 14 November 2018 (Status as of 1 January 2020)


Open article in different language:  DE  |  FR  |  IT
Art. 17 Technical supervision of the facilities

1 The Re­spons­ible Per­son is re­spons­ible for the dir­ect tech­nic­al su­per­vi­sion of the fa­cil­it­ies and in par­tic­u­lar en­sures that the medi­cin­al products are handled ap­pro­pri­ately.

2 They en­sure that the im­port, ex­port and whole­sale trad­ing in medi­cin­al products are in con­form­ity with the GDP rules de­scribed in An­nex 4 and en­sure that the leg­al pro­vi­sions ap­plic­able to thera­peut­ic products are ob­served.

3 They are au­thor­ised to is­sue in­struc­tions with­in their sphere of activ­ity.

4 They and the com­pany man­age­ment jointly en­sure their dep­u­tisa­tion by ad­equately qual­i­fied spe­cial­ists.

5 If the fa­cil­it­ies cease op­er­a­tions, or if op­er­a­tions can be ex­pec­ted to cease im­min­ently, they must re­port this situ­ation to Swiss­med­ic without delay.

6 They may not sit on one of the fa­cil­it­ies’ su­per­vis­ory com­mit­tees and must de­cide on the re­lease or re­jec­tion of batches in­de­pend­ently of the com­pany’s man­age­ment. Swiss­med­ic can grant a li­cence to small fa­cil­it­ies without such se­greg­a­tion if they can­not im­ple­ment the se­greg­a­tion be­cause of their size.

7 If the size and nature of the fa­cil­it­ies per­mit this activ­ity to be per­formed on a part-time basis, re­spons­ib­il­it­ies must be spe­cified in writ­ing and the min­im­um num­ber of hours dur­ing which the per­son must be present in the fa­cil­ity must be de­term­ined.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden